ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,764, issued on June 2, was assigned to GI INNOVATION INC. (Seoul, South Korea).

"Fusion protein preparation comprising IL-2 and CD80 proteins" was invented by Myung Ho Jang (Seoul, South Korea), Young Min Oh (Yongin-si, South Korea) and Heonchang Lim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical formulation with enhanced stability of a fusion protein dimer comprising a modified IL-2 protein and a CD80 protein. The fusion protein dimer comprising an IL-2 protein and a CD80 protein can not only activate immune cells owing to IL-2, but also effectively regulate Treg cells owing to ...